Product Details
RT3 — Triple Receptor Agonist Research Peptide
RT3 is a next-generation research peptide engineered to simultaneously engage three metabolic receptor targets: GLP-1, GIP, and glucagon receptors. This triple agonist mechanism represents a significant advancement over single- and dual-receptor compounds in preclinical metabolic research.
Mechanism of Action
RT3 activates glucagon-like peptide-1 (GLP-1) receptors to potentiate glucose-dependent insulin secretion, glucose-dependent insulinotropic polypeptide (GIP) receptors to enhance incretin signaling, and glucagon receptors to promote energy expenditure and lipid oxidation. The combined activation of all three pathways creates a synergistic metabolic effect studied extensively in preclinical models of obesity and insulin resistance.
Research Applications
- Metabolic pathway modulation and energy homeostasis
- Insulin sensitivity and glucose regulation studies
- Appetite signaling and food intake research
- Body composition and lipid metabolism investigations
- Comparative studies with single- and dual-receptor agonists
Product Specifications
- Quantity: Varied per vial
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: Refrigerate after reconstitution
- Testing: USA lab tested, COA available
For research purposes only. Not for human use or consumption.
Stacey Brady verified owner
Fast delivery and product arrived in perfect shape.
Anonymous verified owner
Fast shipping, great quality.
Kyle verified owner
Good stuff.
Blaine Randolph verified owner
Great stuff.
Angel verified owner
Excellent experience from order to delivery.
Alex Spitler verified owner
Great product.
Bryan W. verified owner
Works like it should, with careful packaging.
Robert L. verified owner
My one stop shop for research compounds.